Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10.52M | $170.0M | 14.08% | +843.2K | 2026-06-30 |
| Gates Foundation Trust | 6.98M | $113.0M | 9.34% | -- | 2026-06-30 |
| Rubric Capital Management LP | 6.40M | $104.0M | 8.57% | +400.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.79M | $61.0M | 5.07% | -74.8K | 2026-06-30 |
| Sumitomo Mitsui Trust Group, Inc. | 2.71M | $43.0M | 3.62% | -484.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.69M | $43.0M | 3.60% | +86.8K | 2026-06-30 |
| State Street Corp | 2.30M | $37.0M | 3.08% | +106.9K | 2026-06-30 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2.22M | $36.0M | 2.97% | -438.8K | 2026-06-30 |
| ARK Investment Management LLC | 2.15M | $35.0M | 2.88% | +86.9K | 2026-06-30 |
| AQR Capital Management LLC | 1.96M | $31.0M | 2.62% | +1.51M | 2026-06-30 |
